Back to search

National and Kapodistrian University of Athens

Μοριακός χαρακτηρισμός του φαινοτύπου μεθυλίωσης των νησίδων CpG (CIMP) στο σποραδικό καρκίνο του παχέος εντέρου

Abstract

dc:description

DNA methylation is important for normal development and cancer pathology. Current notion postulates that DNA methylation of regulatory sequences contributes to carcinogenesis by conferring transcriptional silencing of tumor suppressor genes. Both methylation and demethylation is employed to build up the patterns of genomic methylation that characterize each cell type as a molecular fingerprint. Demethylation is occurring in regulatory sequences while DNA methylation is enriched in regulatory, coding and repeat regions alike. Dnmts the enzymes building up the genomic methylation patterns have being recognized as dual specificity enzymes, acting either as DNA methyltransferases which methylate cytosines in the context of CpG dinucleotides or as deaminases by converting methylated cytosines to thymines. These thymines are recognized in DNA mismatches and are replaced by cytosines via DNA repair pathways. Cancer cells as opposed to normal cells, present abnormal DNA methylation, summarized into hypermethylation of transcription regulatory elements and hypomethylation of the rest of the genome. This situation is best characterized in sporadic colorectal cancers and is called CpG Island Methylator Phenotype (CIMP). CIMP Iis correlated with a common BRAF mutation namely, BRAFV600E. Although, the molecular mechanism of CIMP is currently unknown, a deregulation of Dnmts is implied. Our research reveals that under physiologic conditions Dnmt3a1 exhibits dual enzymatic specificity in mESCs and that its deregulation affects gene expression during mESC differentiation via retinoic acid treatment. More specifically, Dnmt3a1 is responsible for the permanent silencing of pluripotency genes -that are additionally found into chromosomal clusters- and for the efficient expression of a distinct set of genes which are important for organism’s growth and welfare. Moreover, Dnmt3a1 plays a crucial role in maintaining the Imprint DNA methylation in mESCs. Additionally, we find that Dnmt3a1 and the DNA methylation machinery is differentially targeted by wt and mutant BRAFV600E proteins. In light of our findings, we propose that CIMP pathology is directly related to the deregulation of the equilibrium between DNA methylation and cytidine deamination. To resolve this, an experimental system based on mouse colon adult stem cells and samples from CIMP cancer human biopsies is needed. This hypothesis was not further investigated in the present work, due to lack of biological samples.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kotini, Andriana
  • Κοτίνη, Ανδριάνα

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27791

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kotini, Andriana; Κοτίνη, Ανδριάνα. Μοριακός χαρακτηρισμός του φαινοτύπου μεθυλίωσης των νησίδων CpG (CIMP) στο σποραδικό καρκίνο του παχέος εντέρου. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/27791